Global NK Cell Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 NK Cell Therapy Market Overview

• 1.1 Product Overview and Scope of NK Cell Therapy
• 1.2 Classification of NK Cell Therapy by Types
  • 1.2.1 Global NK Cell Therapy Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global NK Cell Therapy Revenue Market Share by Types in 2018
  • 1.2.3 NK Cell Therapies
  • 1.2.4 NK Cell Directed Antibodies
• 1.3 Global NK Cell Therapy Market by Application
  • 1.3.1 Global NK Cell Therapy Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Cancer
  • 1.3.3 Gastrointestinal Diseases
  • 1.3.4 Others
• 1.4 Global NK Cell Therapy Market by Regions
  • 1.4.1 Global NK Cell Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) NK Cell Therapy Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) NK Cell Therapy Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) NK Cell Therapy Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) NK Cell Therapy Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) NK Cell Therapy Status and Prospect (2014-2024)
• 1.5 Global Market Size of NK Cell Therapy (2014-2024)

2 Company Profiles

• 2.1 Nektar Therapeutics
  • 2.1.1 Business Overview
  • 2.1.2 NK Cell Therapy Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Nektar Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Kiadis Pharma
  • 2.2.1 Business Overview
  • 2.2.2 NK Cell Therapy Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Kiadis Pharma NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Chipscreen Biosciences
  • 2.3.1 Business Overview
  • 2.3.2 NK Cell Therapy Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Chipscreen Biosciences NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Innate Pharma SA
  • 2.4.1 Business Overview
  • 2.4.2 NK Cell Therapy Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Innate Pharma SA NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Dragonfly Therapeutics
  • 2.5.1 Business Overview
  • 2.5.2 NK Cell Therapy Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Dragonfly Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Affimed
  • 2.6.1 Business Overview
  • 2.6.2 NK Cell Therapy Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Affimed NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Nkarta Therapeutics
  • 2.7.1 Business Overview
  • 2.7.2 NK Cell Therapy Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Nkarta Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Glycostem Therapeutics
  • 2.8.1 Business Overview
  • 2.8.2 NK Cell Therapy Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Glycostem Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Fate Therapeutics
  • 2.9.1 Business Overview
  • 2.9.2 NK Cell Therapy Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Fate Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 NantWorks
  • 2.10.1 Business Overview
  • 2.10.2 NK Cell Therapy Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 NantWorks NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Fortress Biotech
  • 2.11.1 Business Overview
  • 2.11.2 NK Cell Therapy Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Fortress Biotech NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

3 Global NK Cell Therapy Market Competition, by Players

• 3.1 Global NK Cell Therapy Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 NK Cell Therapy Players Market Share
  • 3.2.2 Top 10 NK Cell Therapy Players Market Share
• 3.3 Market Competition Trend

4 Global NK Cell Therapy Market Size by Regions

• 4.1 Global NK Cell Therapy Revenue and Market Share by Regions
• 4.2 North America NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 4.3 Europe NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 4.5 South America NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa NK Cell Therapy Revenue and Growth Rate (2014-2019)

5 North America NK Cell Therapy Revenue by Countries

• 5.1 North America NK Cell Therapy Revenue by Countries (2014-2019)
• 5.2 USA NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 5.3 Canada NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 5.4 Mexico NK Cell Therapy Revenue and Growth Rate (2014-2019)

6 Europe NK Cell Therapy Revenue by Countries

• 6.1 Europe NK Cell Therapy Revenue by Countries (2014-2019)
• 6.2 Germany NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 6.3 UK NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 6.4 France NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 6.5 Russia NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 6.6 Italy NK Cell Therapy Revenue and Growth Rate (2014-2019)

7 Asia-Pacific NK Cell Therapy Revenue by Countries

• 7.1 Asia-Pacific NK Cell Therapy Revenue by Countries (2014-2019)
• 7.2 China NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 7.3 Japan NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 7.4 Korea NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 7.5 India NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia NK Cell Therapy Revenue and Growth Rate (2014-2019)

8 South America NK Cell Therapy Revenue by Countries

• 8.1 South America NK Cell Therapy Revenue by Countries (2014-2019)
• 8.2 Brazil NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 8.3 Argentina NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 8.4 Colombia NK Cell Therapy Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue NK Cell Therapy by Countries

• 9.1 Middle East and Africa NK Cell Therapy Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 9.3 UAE NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 9.4 Egypt NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria NK Cell Therapy Revenue and Growth Rate (2014-2019)
• 9.6 South Africa NK Cell Therapy Revenue and Growth Rate (2014-2019)

10 Global NK Cell Therapy Market Segment by Type

• 10.1 Global NK Cell Therapy Revenue and Market Share by Type (2014-2019)
• 10.2 Global NK Cell Therapy Market Forecast by Type (2019-2024)
• 10.3 NK Cell Therapies Revenue Growth Rate (2014-2024)
• 10.4 NK Cell Directed Antibodies Revenue Growth Rate (2014-2024)

11 Global NK Cell Therapy Market Segment by Application

• 11.1 Global NK Cell Therapy Revenue Market Share by Application (2014-2019)
• 11.2 NK Cell Therapy Market Forecast by Application (2019-2024)
• 11.3 Cancer Revenue Growth (2014-2019)
• 11.4 Gastrointestinal Diseases Revenue Growth (2014-2019)
• 11.5 Others Revenue Growth (2014-2019)

12 Global NK Cell Therapy Market Size Forecast (2019-2024)

• 12.1 Global NK Cell Therapy Market Size Forecast (2019-2024)
• 12.2 Global NK Cell Therapy Market Forecast by Regions (2019-2024)
• 12.3 North America NK Cell Therapy Revenue Market Forecast (2019-2024)
• 12.4 Europe NK Cell Therapy Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific NK Cell Therapy Revenue Market Forecast (2019-2024)
• 12.6 South America NK Cell Therapy Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa NK Cell Therapy Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology